A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

252

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

January 10, 2022

Study Completion Date

June 19, 2025

Conditions

Ovarian Cancer

Interventions

DRUG

Fluzoparib capsules

DRUG

Placebo capsules

Placebo capsule

Trial Locations (1)

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03863860 - A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients | Biotech Hunter | Biotech Hunter